Article
When AI Meets the FDA: An Evaluation of Large Language Models Performance in Regulatory and Clinical Trial Data Extraction, Synthesis, and Analysis
2025-12-27
Abstract excerpt
<h4>Introduction:</h4> Clinical and population decision-making relies on the systematic evaluation of extensive regulatory evidence. The FDA drug reviews provide detailed information on clinical trial design, enrollment criteria, sample size, randomization, comparators, endpoints, and indications. However, extracting these data is resource-intensive and time-consuming. Generative Artificial Intelligence large lan...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 46362abd-506b-5a1b-b6c7-276bcfb6aab0
- DOI
- 10.64898/2025.12.22.25342875
